Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer [Phase 1]
Phase 1 safety study update for GC1118, a recombinant human anti-EGFR antibody, in advanced solid cancers including gastric and colorectal c…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer [Phase 1]
A Phase 1 study evaluating chemotherapy plus radiation therapy for unresectable, residual, or recurrent colorectal cancer has completed.
-
CLINICAL_TRIALS research · 2016-07-06Clinical Trial Update: Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
This completed clinical trial studied genetic factors related to diarrhea in patients with stage III colorectal cancer receiving chemotherap…
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Combination Chemotherapy in Treating Patients With Colorectal Cancer [Phase 3]
This is an update on a Phase 3 trial evaluating combination chemotherapy for colorectal cancer; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Gene Testing in Patients With Colon Cancer
This clinical trial update covers gene testing in patients with colorectal cancer. The study NCT00003571 has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-07-06Clinical Trial Update: Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer [Phase 2]
A Phase 2 trial evaluating cetuximab and bevacizumab as first-line therapy followed by chemotherapy with/without cetuximab for stage IV colo…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed [Phase 3]
A Phase 3 clinical trial update assessing aspirin as adjuvant therapy for colorectal cancer that has been surgically removed.
-
CLINICAL_TRIALS research · 2016-07-04Clinical Trial Update: Genetic Study of Patients and Families With a History of Colorectal Cancer
A completed genetic study focusing on patients and families with a history of colorectal cancer, sponsored by the Alliance for Clinical Tria…
-
CLINICAL_TRIALS trial_result · 2016-07-04Clinical Trial Update: Screening Tests in Detecting Colorectal Cancer
A completed clinical trial evaluating screening tests for detecting colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2016-07-01Clinical Trial Update: Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial comparing biweekly versus triweekly raltitrexed with oxaliplatin (with or without bevacizumab) as first-line treatment for met…
-
CLINICAL_TRIALS research · 2016-06-30Clinical Trial Update: Fish Oil Supplementation in Gastrointestinal Cancer [NA]
An ongoing clinical trial is investigating fish oil supplementation in gastrointestinal cancers, including colorectal and stomach cancer, wi…
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial update evaluating liposomal SN-38 in metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-29Clinical Trial Update: Nitrous Oxide and Risk of Cancer Recurrence After Colorectal Surgery: A Randomized, Blinded Study [Phase 3]
A completed Phase 3 randomized trial evaluated whether nitrous oxide used during colorectal cancer surgery influences cancer recurrence.
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Acupuncture for Enhanced Recovery After Surgery in Patients Undergoing Laparoscopic Colorectal Cancer Resection [NA]
A completed clinical trial studied acupuncture to enhance recovery after laparoscopic colorectal cancer resection.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Simo Decoction and Acupuncture on POI in Colorectal Cancer [Phase 3]
A Phase 3 trial update indicates completion of a study evaluating Simo Decoction with acupuncture for postoperative ileus in colorectal canc…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 safety and efficacy study of BMS-908662 alone or in combination with Cetuxi…
-
FDA approval · 2016-06-24FDA Approved: OXALIPLATIN — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application for Oxaliplatin from Hospira, Inc., resulting in updated labeling for the product.
-
CLINICAL_TRIALS research · 2016-06-24Clinical Trial Update: Impact of DietarY and LIfestyle Risk Factors on Colorectal Cancer Screening
Clinical trial update examining how dietary and lifestyle risk factors influence colorectal cancer screening, with registry status currently…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Full-spectrum Endoscopy in Colorectal Cancer Screening [NA]
The clinical trial NCT02812550 evaluating full-spectrum endoscopy for colorectal cancer screening has completed. Sponsor listed: Hospital de…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer [Phase 3]
Phase 3 trial comparing capecitabine (Xeloda) with 5-fluorouracil plus low-dose leucovorin in patients who underwent surgery for colorectal …
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy and bevacizumab before surgery, followed by radiolabeled monoclonal antibody therapy, for …
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Trial of Second Generation Designer T Cells in Colorectal Carcinoma [Phase 1]
A Phase 1 trial evaluating second-generation designer T cells for colorectal cancer has been terminated.
-
FDA approval · 2016-06-16FDA Approved: LEVOLEUCOVORIN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s levoleucovorin as an Original Application generic; levoleucovorin is used in cancer regimens w…
-
CLINICAL_TRIALS trial_result · 2016-06-15Clinical Trial Update: Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) Genotype [Phase 2]
Phase 2 trial evaluating cetuximab in refractory colorectal cancer with KRAS mutation and favorable FcγRIIa genotype; results were posted in…
-
CLINICAL_TRIALS research · 2016-06-15Clinical Trial Update: Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical Surgery [Phase 3]
This item reports a Phase 3 clinical trial evaluating Huaier Granule as adjuvant therapy after radical surgery for colorectal cancer. The cu…